UnitLevel 3Undergraduate

BPS3232 Molecular basis of drug action

Faculty of Pharmacy and Pharmaceutical Sciences

BPS3232 Molecular basis of drug action is a level 3, 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2020 in Semester 2 at Parkville. It needs BPS2011 and BPS2021.

Credit points
6
Offered in 2020
Semester 2
Parkville
Assessment
Exam 40%
and 3 other tasks

The 2027 handbook has no page for BPS3232. This is its 2020 entry, the latest one.

Reviews

No reviews yet

No reviews yet. Be the first to review BPS3232.

Requisites

After BPS3232

No unit lists BPS3232 as a prerequisite in the 2020 handbook.

Overview

This unit will introduce students to the different mechanisms of action by which drugs exert their biological activity. It will address the interactions between endogenous ligands and drugs with their receptors, enzymes or nucleic acids, and the way that drugs mimic, oppose or modify those interactions. Students will be introduced to the scope of medicinal chemistry techniques used in contemporary drug discovery.

This will involve the study of:

  • G-protein coupled receptors
  • other receptor types
  • ion channels
  • nuclear hormone receptors
  • drugs interacting with oligonucleotides
  • enzymes and enzyme inhibition

Students in the unit will undertake a significant team-based inquiry project that reflects the role of medicinal chemistry in the drug discovery, design and development process. 

Offerings in 2020

Teaching periodCampusMode
Second semesterParkvilleOn campus

Assessment

  • Poster presentation
    25%
  • Workshops
    15%
  • Mid-Semester test
    20%
  • End-of-semester exam
    40%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Explain central concepts relating to the interaction of endogenous ligands, drugs and therapeutic targets, including:

    • Common receptor classes, agonism/antagonism, inverse agonism and allosteric modulation
    • Enzyme classes including metalloenzymes, their reactions and kinetic properties, and enzyme inhibition
    • DNA oligonucleotide recognition and modification by ligands
    • Peptidomimetics
    • Small molecule structure-activity relationships
  2. 2

    Apply common design approaches (ligand-based, structure-based and mechanism-based design strategies) to propose drug molecules for therapeutic targets

  3. 3

    Acquire skills in researching information and to present the findings in a structured, logical and fluent manner;



  4. 4

    Effectively work in a team to plan, conduct and complete an inquiry project.



Workload and teaching

  • Lectures16 hours
  • Workshops24 hours
  • Eight x1.5-hour online modules (discovery)
  • Sixteen x1-hour interactive lectures
  • Eight x3-hour workshops

Learning resources

Technology resources

For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf

Contacts

Chief Examiners
Dr Tony Hughes
Unit Coordinators
Dr Tony Hughes

Common questions

What are the prerequisites for BPS3232?

You need BPS2011 and BPS2021 before you enrol.

When is BPS3232 offered?

In 2020, BPS3232 runs in Semester 2 at Parkville.

Does BPS3232 have an exam?

Yes. The exam is worth 40% of the final mark, alongside 3 other tasks.

More details

Credit points
6
Level
3
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Not available
Handbook years
2020